Skip to main content
. Author manuscript; available in PMC: 2017 Nov 6.
Published in final edited form as: J Med Chem. 2015 Apr 21;58(11):4638–4647. doi: 10.1021/acs.jmedchem.5b00184

Figure 1.

Figure 1

Illustrations of the in vitro antagonist pharmacology of SHU9119, miniAGRP, 6, and 22 at the mMC3R and mMC4R. A Schild antagonist experimental design was applied and the agonist MTII was utilized in these studies.